Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 11/22/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

ProShares Ultra Nasdaq Biotechnology

BIB | ETF

$56.84

$88.3 M

1.08%

$0.61

1.14%

Vitals

YTD Return

0.4%

1 yr return

31.5%

3 Yr Avg Return

-11.7%

5 Yr Avg Return

0.2%

Net Assets

$88.3 M

Holdings in Top 10

51.2%

52 WEEK LOW AND HIGH

$55.1
$43.23
$68.49

Expenses

OPERATING FEES

Expense Ratio 1.14%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Exchange Traded Fund

Name

As of 11/22/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

ProShares Ultra Nasdaq Biotechnology

BIB | ETF

$56.84

$88.3 M

1.08%

$0.61

1.14%

BIB - Profile

Distributions

  • YTD Total Return 0.4%
  • 3 Yr Annualized Total Return -11.7%
  • 5 Yr Annualized Total Return 0.2%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.58%
DIVIDENDS
  • Dividend Yield 1.1%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    ProShares Ultra Nasdaq Biotechnology
  • Fund Family Name
    ProShares Trust
  • Inception Date
    Apr 08, 2010
  • Shares Outstanding
    1950000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Michael Neches

Fund Description

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.The Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. The Index includes companies listed on the Nasdaq Global Select Market or the Nasdaq Global Market (which include both U.S. and non-U.S. companies) that are included in the biotechnology or pharmaceuticals subsectors, according to the Industry Classification Benchmark. The biotechnology and pharmaceutical subsectors include companies engaged in research into and development of biological substances for the purposes of drug discovery and diagnostic development and manufacturers of prescription or over-the-counter drugs. Companies are selected based on market capitalization and liquidity. Selected companies are then weighted based on market capitalization. The Index’s composition and the assigned weights are reevaluated every December, with additional weight adjustments occurring in March, June, and September. The Index is constructed and maintained by Nasdaq Inc. More information about the Index can be found using the Bloomberg ticker symbol “NBI.”Under normal circumstances, the Fund will obtain leveraged exposure to at least 80% of its total assets in components of the Index or in instruments with similar economic characteristics.The Fund will invest principally in the financial instruments listed below.●Equity Securities — Common stock issued by public companies.●Derivatives — Financial instruments whose value is derived from the value of an underlying asset or rate, such as stocks, bonds, ETFs, interest rates or indexes. These derivatives principally include:○Swap Agreements — Contracts entered into primarily with major global financial institutions for a specified period ranging from a day to more than one year. In a standard swap transaction, two parties agree to exchange or “swap” payments based on the change in value of an underlying asset or benchmark. For example, two parties may agree to exchange the return (or differentials in rates of returns) earned or realized on a particular investment or instrument.●Money Market Instruments — The Fund expects that any cash balances maintained in connection with its use of derivatives will typically be held in high quality, short-term money market instruments, for example:○U.S. Treasury Bills — U.S. government securities that have initial maturities of one year or less, and are supported by the full faith and credit of the U.S. government.○Repurchase Agreements — Contracts in which a seller of securities, usually U.S. government securities or other money market instruments, agrees to buy the securities back at a specified time and price.ProShare Advisors uses a mathematical approach to investing in which it determines the type, quantity and mix of investment positions that it believes, in combination, the Fund should hold to produce daily returns consistent with the Daily Target. For these purposes a day is measured from the time of one net asset value (“NAV”) calculation to the next.The Fund seeks to remain fully invested at all times in financial instruments that, in combination, provide leveraged exposure consistent with the investment objective, without regard to market conditions, trends or direction. However, the Fund may invest in or gain exposure to only a representative sample of the securities in the Index or to securities not contained in the Index or in financial instruments, with the intent of obtaining leveraged exposure consistent with the investment objective.The Fund seeks to rebalance its portfolio each day so that its exposure to the Index is consistent with the Daily Target. The Index’s movements during the day will affect whether the Fund’s portfolio needs to be rebalanced. For example, if the Index has risen on a given day, net assets of the Fund should rise (assuming there were no Creation Unit redemptions). As a result, the Fund’s exposure will need to be increased. Conversely, if the Index has fallen on a given day, net assets of the Fund should fall (assuming there were no Creation Units issued). As a result, the Fund’s exposure will need to be decreased.Please see “Investment Objectives, Principal Investment Strategies and Related Risks” in the Fund’s Prospectus for additional details.
Read More

BIB - Performance

Return Ranking - Trailing

Period BIB Return Category Return Low Category Return High Rank in Category (%)
YTD 0.4% -69.2% 140.0% 87.34%
1 Yr 31.5% -59.2% 181.8% 67.72%
3 Yr -11.7%* -50.2% 35.6% 85.44%
5 Yr 0.2%* -40.0% 58.2% 74.68%
10 Yr -0.4%* -37.5% 43.5% 82.61%

* Annualized

Return Ranking - Calendar

Period BIB Return Category Return Low Category Return High Rank in Category (%)
2023 -1.1% -56.9% 257.9% 82.28%
2022 -28.9% -91.0% 124.5% 31.01%
2021 -6.0% -79.4% 168.2% 79.75%
2020 39.8% -97.4% 132.6% 23.42%
2019 46.7% -53.1% 229.8% 44.23%

Total Return Ranking - Trailing

Period BIB Return Category Return Low Category Return High Rank in Category (%)
YTD 0.4% -69.2% 140.0% 87.34%
1 Yr 31.5% -59.2% 181.8% 67.72%
3 Yr -11.7%* -50.2% 35.6% 85.44%
5 Yr 0.2%* -40.0% 58.2% 74.68%
10 Yr -0.4%* -37.5% 43.5% 82.61%

* Annualized

Total Return Ranking - Calendar

Period BIB Return Category Return Low Category Return High Rank in Category (%)
2023 -1.1% -55.8% 259.6% 82.91%
2022 -28.8% -91.0% 130.7% 31.01%
2021 -6.0% -79.4% 168.2% 84.18%
2020 39.8% -97.4% 132.6% 24.05%
2019 46.7% -52.7% 231.9% 49.36%

BIB - Holdings

Concentration Analysis

BIB Category Low Category High BIB % Rank
Net Assets 88.3 M 1.5 M 22.2 B 38.32%
Number of Holdings 232 5 2009 21.60%
Net Assets in Top 10 48.3 M 1.08 M 9.23 B 39.51%
Weighting of Top 10 51.22% 13.9% 185.3% 64.20%

Top 10 Holdings

  1. U.S. Treasury Bills 10.47%
  2. Gilead Sciences, Inc. 5.81%
  3. Regeneron Pharmaceuticals, Inc. 5.71%
  4. Amgen, Inc. 5.16%
  5. Vertex Pharmaceuticals, Inc. 5.15%
  6. Total Return Swap 5.14%
  7. Repurchase Agreement 4.42%
  8. Repurchase Agreement 3.41%
  9. Total Return Swap 3.30%
  10. AstraZeneca plc 2.65%

Asset Allocation

Weighting Return Low Return High BIB % Rank
Stocks 		65.37% 0.00% 375.12% 59.88%
Other 		22.40% -7.39% 99.69% 38.89%
Cash 		13.25% 0.00% 104.72% 32.72%
Preferred Stocks 		0.00% 0.00% 1.99% 49.38%
Convertible Bonds 		0.00% 0.00% 0.32% 53.70%
Bonds 		0.00% 0.00% 37.59% 58.64%

Stock Sector Breakdown

Weighting Return Low Return High BIB % Rank
Utilities 		0.00% 0.00% 100.00% 60.14%
Technology 		0.00% 0.00% 100.00% 76.92%
Real Estate 		0.00% 0.00% 100.00% 55.24%
Industrials 		0.00% 0.00% 100.00% 77.62%
Healthcare 		0.00% 0.00% 100.00% 4.20%
Financial Services 		0.00% 0.00% 100.00% 73.43%
Energy 		0.00% 0.00% 100.00% 63.64%
Communication Services 		0.00% 0.00% 100.00% 76.92%
Consumer Defense 		0.00% 0.00% 52.46% 69.93%
Consumer Cyclical 		0.00% 0.00% 94.15% 75.52%
Basic Materials 		0.00% 0.00% 100.00% 52.45%

Stock Geographic Breakdown

Weighting Return Low Return High BIB % Rank
US 		65.37% 0.00% 375.12% 59.88%
Non US 		0.00% 0.00% 20.00% 48.77%

BIB - Expenses

Operational Fees

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.14% 0.68% 5.63% 76.58%
Management Fee 0.75% 0.00% 0.95% 42.51%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 4.75% 4.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A N/A N/A N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 266.00% 23.31%

BIB - Distributions

Dividend Yield Analysis

BIB Category Low Category High BIB % Rank
Dividend Yield 1.08% 0.00% 18.26% 74.85%

Dividend Distribution Analysis

BIB Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Monthly Quarterly

Net Income Ratio Analysis

BIB Category Low Category High BIB % Rank
Net Income Ratio -0.58% -2.77% 2.92% 50.00%

Capital Gain Distribution Analysis

BIB Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

BIB - Fund Manager Analysis

Managers

Michael Neches

Start Date

Tenure

Tenure Rank

Oct 01, 2013

8.67

8.7%

Michael Neches joined ProShare Advisors in 2000, and presently serves as a Senior Portfolio Manager. He previously served as the Senior Portfolio Manager responsible for the company’s commodities desk for two years, as a Portfolio Manager and team lead, as an Associate Portfolio Manager and as a Portfolio Analyst. Mr. Neches earned a Bachelor of Science in Finance from the University of Maryland, College Park and an MBA from Georgetown University.

Tarak Davé

Start Date

Tenure

Tenure Rank

Apr 30, 2018

4.09

4.1%

Tarak Dave ProFund Advisors LLC: Portfolio Manager since March 2018, Associate Portfolio Manager from November 2015 to March 2018, Senior Portfolio Analyst from May 2014 to October 2015 and Portfolio Analyst from April 2011 to April 2014.

Tenure Analysis

Category Low Category High Category Average Category Mode
1.79 28.9 9.84 8.67

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.